Literature DB >> 28355568

A Sequentially Priming Phosphorylation Cascade Activates the Gliomagenic Transcription Factor Olig2.

Jing Zhou1, An-Chi Tien2, John A Alberta1, Scott B Ficarro3, Amelie Griveau2, Yu Sun1, Janhavee S Deshpande4, Joseph D Card4, Meghan Morgan-Smith5, Wojciech Michowski6, Rintaro Hashizume7, C David James7, Keith L Ligon8, William D Snider5, Peter Sicinski6, Jarrod A Marto9, David H Rowitch10, Charles D Stiles11.   

Abstract

During development of the vertebrate CNS, the basic helix-loop-helix (bHLH) transcription factor Olig2 sustains replication competence of progenitor cells that give rise to neurons and oligodendrocytes. A pathological counterpart of this developmental function is seen in human glioma, wherein Olig2 is required for maintenance of stem-like cells that drive tumor growth. The mitogenic/gliomagenic functions of Olig2 are regulated by phosphorylation of a triple serine motif (S10, S13, and S14) in the amino terminus. Here, we identify a set of three serine/threonine protein kinases (glycogen synthase kinase 3α/β [GSK3α/β], casein kinase 2 [CK2], and cyclin-dependent kinases 1/2 [CDK1/2]) that are, collectively, both necessary and sufficient to phosphorylate the triple serine motif. We show that phosphorylation of the motif itself serves as a template to prime phosphorylation of additional serines and creates a highly charged "acid blob" in the amino terminus of Olig2. Finally, we show that small molecule inhibitors of this forward-feeding phosphorylation cascade have potential as glioma therapeutics.
Copyright © 2017 The Author(s). Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  CDK; CK2; GSK3; NPCs; Olig2; casein kinase 2; cyclin-dependent kinase; glioma; glycogen synthase kinase 3; neural progenitor cells; phosphorylation; protein kinase

Mesh:

Substances:

Year:  2017        PMID: 28355568      PMCID: PMC5394178          DOI: 10.1016/j.celrep.2017.03.003

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  49 in total

Review 1.  GSK-3: tricks of the trade for a multi-tasking kinase.

Authors:  Bradley W Doble; James R Woodgett
Journal:  J Cell Sci       Date:  2003-04-01       Impact factor: 5.285

2.  Moving beyond rules: the development of a central nervous system multiparameter optimization (CNS MPO) approach to enable alignment of druglike properties.

Authors:  Travis T Wager; Xinjun Hou; Patrick R Verhoest; Anabella Villalobos
Journal:  ACS Chem Neurosci       Date:  2010-03-25       Impact factor: 4.418

3.  Inhibition of p53 DNA binding function by the MDM2 protein acidic domain.

Authors:  Brittany Cross; Lihong Chen; Qian Cheng; Baozong Li; Zhi-Min Yuan; Jiandong Chen
Journal:  J Biol Chem       Date:  2011-03-17       Impact factor: 5.157

4.  Disruption of CK2beta in embryonic neural stem cells compromises proliferation and oligodendrogenesis in the mouse telencephalon.

Authors:  Emmanuelle Huillard; Léa Ziercher; Olivier Blond; Michael Wong; Jean-Christophe Deloulme; Serhiy Souchelnytskyi; Jacques Baudier; Claude Cochet; Thierry Buchou
Journal:  Mol Cell Biol       Date:  2010-04-05       Impact factor: 4.272

5.  Requirement for glycogen synthase kinase-3beta in cell survival and NF-kappaB activation.

Authors:  K P Hoeflich; J Luo; E A Rubie; M S Tsao; O Jin; J R Woodgett
Journal:  Nature       Date:  2000-07-06       Impact factor: 49.962

6.  The central nervous system-restricted transcription factor Olig2 opposes p53 responses to genotoxic damage in neural progenitors and malignant glioma.

Authors:  Shwetal Mehta; Emmanuelle Huillard; Santosh Kesari; Cecile L Maire; Diane Golebiowski; Emily P Harrington; John A Alberta; Michael F Kane; Matthew Theisen; Keith L Ligon; David H Rowitch; Charles D Stiles
Journal:  Cancer Cell       Date:  2011-03-08       Impact factor: 31.743

7.  Human cortical glial tumors contain neural stem-like cells expressing astroglial and neuronal markers in vitro.

Authors:  Tatyana N Ignatova; Valery G Kukekov; Eric D Laywell; Oleg N Suslov; Frank D Vrionis; Dennis A Steindler
Journal:  Glia       Date:  2002-09       Impact factor: 7.452

8.  Targeting protein kinase CK2 suppresses prosurvival signaling pathways and growth of glioblastoma.

Authors:  Ying Zheng; Braden C McFarland; Denis Drygin; Hao Yu; Susan L Bellis; Hyunsoo Kim; Markus Bredel; Etty N Benveniste
Journal:  Clin Cancer Res       Date:  2013-09-13       Impact factor: 12.531

9.  Inhibition of Casein kinase-2 induces p53-dependent cell cycle arrest and sensitizes glioblastoma cells to tumor necrosis factor (TNFα)-induced apoptosis through SIRT1 inhibition.

Authors:  D Dixit; V Sharma; S Ghosh; V S Mehta; E Sen
Journal:  Cell Death Dis       Date:  2012-02-09       Impact factor: 8.469

10.  Casein kinase 2α regulates glioblastoma brain tumor-initiating cell growth through the β-catenin pathway.

Authors:  R T Nitta; S Gholamin; A H Feroze; M Agarwal; S H Cheshier; S S Mitra; G Li
Journal:  Oncogene       Date:  2014-09-22       Impact factor: 9.867

View more
  14 in total

Review 1.  Harnessing OLIG2 function in tumorigenicity and plasticity to target malignant gliomas.

Authors:  Jennifer Kosty; Fanghui Lu; Robert Kupp; Shwetal Mehta; Q Richard Lu
Journal:  Cell Cycle       Date:  2017-08-14       Impact factor: 4.534

Review 2.  Epigenetic modifications-insight into oligodendrocyte lineage progression, regeneration, and disease.

Authors:  Alexander Gregath; Qing Richard Lu
Journal:  FEBS Lett       Date:  2018-02-22       Impact factor: 4.124

3.  Phosphorylation by casein kinase 2 enhances the interaction between ER-phagy receptor TEX264 and ATG8 proteins.

Authors:  Haruka Chino; Akinori Yamasaki; Koji L Ode; Hiroki R Ueda; Nobuo N Noda; Noboru Mizushima
Journal:  EMBO Rep       Date:  2022-04-13       Impact factor: 9.071

Review 4.  A glial blueprint for gliomagenesis.

Authors:  Dylan Laug; Stacey M Glasgow; Benjamin Deneen
Journal:  Nat Rev Neurosci       Date:  2018-07       Impact factor: 34.870

5.  A Glial Signature and Wnt7 Signaling Regulate Glioma-Vascular Interactions and Tumor Microenvironment.

Authors:  Amelie Griveau; Giorgio Seano; Samuel J Shelton; Robert Kupp; Arman Jahangiri; Kirsten Obernier; Shanmugarajan Krishnan; Olle R Lindberg; Tracy J Yuen; An-Chi Tien; Jennifer K Sabo; Nancy Wang; Ivy Chen; Jonas Kloepper; Louis Larrouquere; Mitrajit Ghosh; Itay Tirosh; Emmanuelle Huillard; Arturo Alvarez-Buylla; Michael C Oldham; Anders I Persson; William A Weiss; Tracy T Batchelor; Anat Stemmer-Rachamimov; Mario L Suvà; Joanna J Phillips; Manish K Aghi; Shwetal Mehta; Rakesh K Jain; David H Rowitch
Journal:  Cancer Cell       Date:  2018-04-19       Impact factor: 31.743

6.  Olig2 and Hes regulatory dynamics during motor neuron differentiation revealed by single cell transcriptomics.

Authors:  Andreas Sagner; Zachary B Gaber; Julien Delile; Jennifer H Kong; David L Rousso; Caroline A Pearson; Steven E Weicksel; Manuela Melchionda; S Neda Mousavy Gharavy; James Briscoe; Bennett G Novitch
Journal:  PLoS Biol       Date:  2018-02-01       Impact factor: 8.029

7.  Fe3O4@Au composite magnetic nanoparticles modified with cetuximab for targeted magneto-photothermal therapy of glioma cells.

Authors:  Qianling Lu; Xinyu Dai; Peng Zhang; Xiao Tan; Yuejiao Zhong; Cheng Yao; Mei Song; Guili Song; Zhenghai Zhang; Gang Peng; Zhirui Guo; Yaoqi Ge; Kangzhen Zhang; Yuntao Li
Journal:  Int J Nanomedicine       Date:  2018-04-23

8.  mzStudio: A Dynamic Digital Canvas for User-Driven Interrogation of Mass Spectrometry Data.

Authors:  Scott B Ficarro; William M Alexander; Jarrod A Marto
Journal:  Proteomes       Date:  2017-08-01

Review 9.  The developmental origin of brain tumours: a cellular and molecular framework.

Authors:  Roberta Azzarelli; Benjamin D Simons; Anna Philpott
Journal:  Development       Date:  2018-05-14       Impact factor: 6.868

Review 10.  Epigenetic regulation of oligodendrocyte myelination in developmental disorders and neurodegenerative diseases.

Authors:  Kalen Berry; Jiajia Wang; Q Richard Lu
Journal:  F1000Res       Date:  2020-02-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.